Literature DB >> 1142122

Drinking behaviour in the cat induced by renin, angiotensin I, II and isoprenaline.

M J Cooling, M D Day.   

Abstract

1. Angiotensin I, II and hog renin, infused into the lateral cerebral ventricles (I.C.V.) of water replete cats, each induced water drinking behaviour. 2. Intravenous infusion of high doses of angiotensin I or II also elicited a drinking response. The dipsogenic effect of I.V. renin was not marked. 3. Drinking in response to I.C.V. angiotensin II was abolished after autonomic ganglion blockade with I.V. hexamethonium or pempidine and was significantly reduced after I.V. atropine methonitrate. 4. The dipsogenic response to I.C.V. angiotensin II was unaffected by either peripheral adrenergic neurone blockade with I.V. bethanidine, alpha-adrenoceptor blockade with phentolamine or beta-adrenoceptor blockade with sotalol. 5. Atropine, atropine methonitrate, hexamethonium and pempidine given I.C.V did not inhibit the diposgenic response to I.C.V. angiotensin II. 6. Bethanidine I.C.V. produced a dose related reduction in the dipsogenic response to I.C.V. angiotensin II. 7. The alpha-adrenoceptor blocking agents tolazoline and phenoxybenzamine given I.C.V did not affect angiotensin induced drinking but the response was regularly inhibited by phentolamine I.C.V. 8. The beta-adrenoceptor blocking agents propranolol and practolol given I.C.V. each inhibited angiotensin induced drinking. The L-isomer of propranolol was a more effective blocker than the D-isomer. 9. Isoprenaline given I.C.V induced drinking in ten of sixteen cats. Subcutaneous administration of isoprenaline also elicited drinking but the onset of the response was delayed and the amount consumed slightly less than after I.C.V infusion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1142122      PMCID: PMC1330765          DOI: 10.1113/jphysiol.1975.sp010801

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  25 in total

1.  The variation in the water consumption of cats.

Authors:  D S CARVER; H N WATERHOUSE
Journal:  Proc Anim Care Panel       Date:  1962-12

2.  SEIZURES INDUCED BY INTRAVENTRICULAR SODIUM.

Authors:  G H GLASER; G WOLF
Journal:  Nature       Date:  1963-10-05       Impact factor: 49.962

3.  Eating or drinking elicited by direct adrenergic or cholinergic stimulation of hypothalamus.

Authors:  S P GROSSMAN
Journal:  Science       Date:  1960-07-29       Impact factor: 47.728

4.  The complete dependence of beta-adrenergic drinking on the renal dipsogen.

Authors:  K A Houpt; A N Epstein
Journal:  Physiol Behav       Date:  1971-12

5.  Effects of intracranial cholinergic stimulation in rats on drinking, egg, and heart rate.

Authors:  E M Macphail
Journal:  J Comp Physiol Psychol       Date:  1968-02

6.  Effects of adrenoceptor blocking agents on body temperature.

Authors:  W Feldberg; P N Saxena
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

7.  The role of a renal thirst factor in drinking induced by extracellular stimuli.

Authors:  J T Fitzsimons
Journal:  J Physiol       Date:  1969-04       Impact factor: 5.182

8.  The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst.

Authors:  J T Fitzsimons; B J Simons
Journal:  J Physiol       Date:  1969-07       Impact factor: 5.182

9.  The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon.

Authors:  J T Fitzsimons
Journal:  J Physiol       Date:  1971-04       Impact factor: 5.182

10.  Drinking induced by injection of angiotensin into the rain of the rat.

Authors:  A N Epstein; J T Fitzsimons; B J Rolls
Journal:  J Physiol       Date:  1970-09       Impact factor: 5.182

View more
  1 in total

Review 1.  Neural populations for maintaining body fluid balance.

Authors:  Takako Ichiki; Vineet Augustine; Yuki Oka
Journal:  Curr Opin Neurobiol       Date:  2019-03-02       Impact factor: 7.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.